Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Juno Therapeutics
company
About
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $120M
- Industries
- Biotechnology,Clinical Trials,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$254M
Juno Therapeutics has raised a total of
$254M
in funding over 2 rounds. Their latest funding was raised on
Aug 5, 2014 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2014 | Series B | $134M | 1 | — | — | Detail |
| Dec 3, 2013 | Series A | $120M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Juno Therapeutics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
